Skip to main content
. 2022 Aug 18;78(1):9–15. doi: 10.1093/gerona/glac169

Table 1.

Descriptive Characterization of the HABS-HD Sample Included in the Analyses

Total Cohort
N = 1 328
Mexican American
N = 669
Non-Hispanic White
N = 659
Statistic
Age 66.10 (8.51) 68.92 (8.33) 63.23(7.70) F = 166.95, p < .001
Education 12.68 (4.7) 15.59 (2.58) 9.71 (4.54) F = 847.59, p < .001
Gender (% male) 36% 30% 41% χ 2 = 18.52, p < .001
MMSE 28.07 (2.30) 29.19 (1.01) 26.94 (2.66) F = 419.06, p < .001
Tug (s) 9.66 (2.30) 9.39 (2.03) 9.94 (2.51) F = 18.29, p < .001
SPPB total 10.88 (1.82) 11.04 (1.68) 10.72 (2.51) F = 9.71, p < .001
Aβ 40 pg/mL 250.81 (65.93) 264.98 (64.36) 236.42 (64.42) F = 62.63, p < .001
Aβ 42 pg/mL 11.99 (3.25) 12.22 (3.12) 11.77 (3.36) F = 6.03, p = .014
Tau pg/mL 2.44 (.928) 2.33 (.933) 6.39 (.911) F = 17.86, p < .001
NfL pg/mL 18.18 (11.37) 19.87 (11.00) 16.46 (11.48) F = 29.23, p < .001
Hypertension (% yes) 61.8% 65.4% 58.3% χ 2 = 7.10, p < .008
Hyperlipidemia (% yes) 64.6% 66.6% 63.1% χ 2 = 1.38, p < .001
Diabetes mellitus (% yes) 23.3% 35.0% 11.8% χ 2 = 18.52, p < .001

Notes: Aβ40 = plasma beta amyloid 40; Aβ42 = plasma beta amyloid 42; MMSE = Mini Mental State Examination; NfL = plasma neurofilament light; SPPB = Short Physical Performance Battery; tau = plasma total tau. All p values < .005.